| abstract |
Present disclosure relates to compound and the pharmaceutically acceptable salt thereof of the formula (I) as mPGES 1 inhibitor.These compounds are the inhibitor of mPGES 1 (mPGES 1) enzyme, and therefore can be used for pain and/or inflammation that treatment is caused by multiple disease or disease (such as asthma, osteoarthritis, rheumatoid arthritis, acute or chronic pain and neurodegenerative disease). |